Health Care

WebMD CEO Departs By 'Mutual Agreement'

David Schlanger is out as chief executive at WebMD Health Corp., the company said Monday, after a three-year stint leading the health-care advice website.

Insider Q&A: Why so little relief on pricey biologic drugs

Drugs made from living cells, instead of by mixing chemicals, have brought major advances since the late 1990s to the treatment of various cancers, immune system disorders, growth hormone deficiency and eye diseases.

US regulators: Official recall of 1M Samsung Note 7 phones

U.S. safety regulators announced a formal recall of Samsung's Galaxy Note 7 smartphone Thursday after a spate of fires led to injuries and property damage — along with a global marketing headache for the South Korean tech giant.

Oregon settles lawsuit for botched health care rollout

Oregon settled with a California software giant in a lawsuit that accused Oracle America Inc. of collecting tens of millions of dollars to create a state health care exchange website that didn't work.

Bayer-Monsanto's $66B Deal Roils Regulators and Now Politicians

Bayer AG’s $66 billion purchase of Monsanto (NYSE:MON) is facing a nearly unprecedented wall of regulatory and political scrutiny that investors and analysts believe will eventually kill the biggest merger of 2016, the FOX Business Network has learned.

Galaxy Note 7 recall shows challenges of stronger batteries

Samsung's recall of 2.5 million Galaxy Note 7 phones after several dozen caught fire and exploded may stem from a subtle manufacturing error, but it highlights the challenge electronics makers face in packing ever more battery power into ever thinner phones, while rushing for faster release dates.

Mylan CEO to Testify Before House Over EpiPen Pricing

Mylan NL Chief Executive Officer Heather Bresch will appear at a Sept. 21 congressional hearing over price increases for its allergy auto-injector EpiPen, the U.S. House of Representatives Oversight Committee said in a statement on Wednesday.